0001209191-21-035152.txt : 20210521
0001209191-21-035152.hdr.sgml : 20210521
20210521211136
ACCESSION NUMBER: 0001209191-21-035152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210520
FILED AS OF DATE: 20210521
DATE AS OF CHANGE: 20210521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 21950920
MAIL ADDRESS:
STREET 1: MYRIAD GENETICS
STREET 2: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 294-1687
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-20
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001238403
SPIEGELMAN DANIEL K
C/O SPRUCE BIOSCIENCES, INC.
2001 JUNIPERO SERRA BLVD., SUITE 640
DALY CITY
CA
94014
1
0
0
0
Stock Option (Right to Buy)
15.24
2021-05-20
4
A
0
6667
0.00
A
2031-05-19
Common Stock
6667
6667
D
The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2022 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan).
/s/ Samir Gharib, Attorney-in-Fact
2021-05-21